Back to Search Start Over

Molecular basis of human noradrenaline transporter reuptake and inhibition.

Authors :
Tan J
Xiao Y
Kong F
Zhang X
Xu H
Zhu A
Liu Y
Lei J
Tian B
Yuan Y
Yan C
Source :
Nature [Nature] 2024 Aug; Vol. 632 (8026), pp. 921-929. Date of Electronic Publication: 2024 Jul 24.
Publication Year :
2024

Abstract

Noradrenaline, also known as norepinephrine, has a wide range of activities and effects on most brain cell types <superscript>1</superscript> . Its reuptake from the synaptic cleft heavily relies on the noradrenaline transporter (NET) located in the presynaptic membrane <superscript>2</superscript> . Here we report the cryo-electron microscopy (cryo-EM) structures of the human NET in both its apo state and when bound to substrates or antidepressant drugs, with resolutions ranging from 2.5 Å to 3.5 Å. The two substrates, noradrenaline and dopamine, display a similar binding mode within the central substrate binding site (S1) and within a newly identified extracellular allosteric site (S2). Four distinct antidepressants, namely, atomoxetine, desipramine, bupropion and escitalopram, occupy the S1 site to obstruct substrate transport in distinct conformations. Moreover, a potassium ion was observed within sodium-binding site 1 in the structure of the NET bound to desipramine under the KCl condition. Complemented by structural-guided biochemical analyses, our studies reveal the mechanism of substrate recognition, the alternating access of NET, and elucidate the mode of action of the four antidepressants.<br /> (© 2024. The Author(s), under exclusive licence to Springer Nature Limited.)

Details

Language :
English
ISSN :
1476-4687
Volume :
632
Issue :
8026
Database :
MEDLINE
Journal :
Nature
Publication Type :
Academic Journal
Accession number :
39048818
Full Text :
https://doi.org/10.1038/s41586-024-07719-z